Mitochondrial calcium function is altered by lithium in hippocampal cell culture and triple transgenic for Alzheimer’s disease

Abstract

AbstractBackgroundCalcium (Ca2+) regulate many functions in neuronal and glial cells. The Mitochondrial Calcium Uniporter (Mcu) complex is thought to be the primary pathway for Ca2+ entry into mitochondria. The Mcu protein has an important role in regulating mitochondrial Ca2+ homeostasis. Dysregulation of mitochondrial Ca2+ homeostasis has been implicated in various pathological conditions, such as Alzheimer disease. AD pathology is characterized by the progressive accumulation of amyloid β‐peptide and neurofibrillary tangles. In AD patients a significant increase in an oxidative damage and decrease in energy metabolism resulting in a mitochondrial calcium disbalance. Lithium has been used for decades to treat neurodegenerative diseases, as it has an action on several intracellular organelles, including mitochondria. The lithium regulates calcium channels, decreases oxidative stress and increases autophagic processes. Therefore, we aim to analyze whether chronic treatment with lithium in primary cultures of hippocampal neurons and in the hippocampus of triple transgenic animals for Alzheimer’s disease (3xtgAD).MethodThe cultures were treated for 7 days (dose of 0.02; 0.2 and 2mM) and 3xtgAD for 8 months (doses of 1mM and 2mM). The hippocampus were analysed by proteomic and transcriptomics.ResultOur results showed that lithium increases Mcu and Micu 3 proteins, showing that lithium has an effect on the modulation of mitochondrial calcium channels that should be explored.ConclusionMitochondrial calcium is an important mechanism for understanding neurodegenerative diseases and lithium can reverse Alzheimer’s disease‐related dysfunction.